241
Views
12
CrossRef citations to date
0
Altmetric
Original Article

A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease*

, , &
Pages 2181-2187 | Accepted 03 Jun 2008, Published online: 18 Jun 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hans C Ebbers, Michael Muenzberg & Huub Schellekens. (2012) The safety of switching between therapeutic proteins. Expert Opinion on Biological Therapy 12:11, pages 1473-1485.
Read now
C Kelaidi & P Fenaux. (2010) Darbepoetin alfa in anemia of myelodysplastic syndromes: present and beyond. Expert Opinion on Biological Therapy 10:4, pages 605-614.
Read now

Articles from other publishers (10)

Bradley A. Warady, Sylvie Meyer Reigner, Chitra Tirodkar & Dorota Drozdz. (2023) Subcutaneous C.E.R.A. for the Maintenance Treatment of Anemia in Pediatric Patients With CKD: A Phase 2, Open-Label, Single-Arm, Multicenter Study. American Journal of Kidney Diseases 81:6, pages 684-694.e1.
Crossref
Edmund YM Chung, Suetonia C Palmer, Valeria M Saglimbene, Jonathan C Craig, Marcello Tonelli & Giovanni FM Strippoli. (2023) Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2023:2.
Crossref
Hidetoshi Kanai, Masaomi Nangaku, Reiko Nagai, Nobuhiko Okuda, Kyo Kurata, Takashi Nagakubo, Yukihiro Endo & Alexander Cobitz. (2021) Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients. Therapeutic Apheresis and Dialysis 25:6, pages 979-987.
Crossref
Anja St Clair-Jones, Francesca Prignano, Joao Goncalves, Muriel Paul & Philipp Sewerin. (2020) Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review. Rheumatology and Therapy 7:4, pages 741-757.
Crossref
Tonci Brkovic, Eliana Burilovic & Livia Puljak. (2018) Risk Factors Associated with Pain on Chronic Intermittent Hemodialysis: A Systematic Review. Pain Practice 18:2, pages 247-268.
Crossref
Georgios Vlachopanos, Theodoros I. Kassimatis & Athanasios Agrafiotis. (2015) Perioperative administration of high-dose recombinant human erythropoietin for delayed graft function prevention in kidney transplantation: a meta-analysis. Transplant International 28:3, pages 330-340.
Crossref
Suetonia C Palmer, Valeria Saglimbene, Jonathan C Craig, Sankar D Navaneethan & Giovanni FM Strippoli. (2014) Darbepoetin for the anaemia of chronic kidney disease. Cochrane Database of Systematic Reviews 2014:10.
Crossref
Wai H. Lim, Doris Chan, Neil Boudville, Susan Pellicano, Helen Herson, Harry Moody, Brian Hutchison, Marianne Snedeker & Gursharan Dogra. (2012) Patients' Perceptions of Subcutaneous Delivery of Darbepoetin Alfa by Autoinjector Prefilled Pen Versus Prefilled Syringe: A Randomized, Crossover Study. Clinical Therapeutics 34:9, pages 1948-1953.
Crossref
Robert N. Foley. (2010) Emerging erythropoiesis-stimulating agents. Nature Reviews Nephrology 6:4, pages 218-223.
Crossref
June D Cody, Conal Daly, Marion K Campbell, Izhar Khan, Kannaiyan S Rabindranath, Luke Vale, Sheila A Wallace, Alison M MacLeod, Adrian M Grant, Susan Pennington, Ionut Nistor, Davide Bolignano & Angela C Webster. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.